25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Pharnext SA
Buy, Hold or Sell?

Let's analyze Pharnext together

I guess you are interested in Pharnext SA. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Pharnext SA. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Pharnext SA

I send you an email if I find something interesting about Pharnext SA.

1. Quick Overview

1.1. Quick analysis of Pharnext (30 sec.)










1.2. What can you expect buying and holding a share of Pharnext? (30 sec.)

How much money do you get?

How much money do you get?
€0.00
When do you have the money?
1 year
How often do you get paid?
20.0%

What is your share worth?

Current worth
€-2.57
Expected worth in 1 year
€-2.95
How sure are you?
30.0%

+ What do you gain per year?

Total Gains per Share
€-0.38
Return On Investment
-189,871.5%

For what price can you sell your share?

Current Price per Share
€0.00
Expected price per share
€0.0001 - €0.0002
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Pharnext (5 min.)




Live pricePrice per Share (EOD)
€0.00

2.2. Growth of Pharnext (5 min.)




Is Pharnext growing?

Current yearPrevious yearGrowGrow %
How rich?-$35.7m-$34.4m-$1.3m-3.7%

How much money is Pharnext making?

Current yearPrevious yearGrowGrow %
Making money-$29m-$40.5m$11.5m39.7%
Net Profit Margin-275,174.2%-6,889,947.0%--

How much money comes from the company's main activities?

2.3. Financial Health of Pharnext (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Pharnext?

Welcome investor! Pharnext's management wants to use your money to grow the business. In return you get a share of Pharnext.

First you should know what it really means to hold a share of Pharnext. And how you can make/lose money.

Speculation

The Price per Share of Pharnext is €0.0002. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Pharnext.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Pharnext, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €-2.57. Based on the TTM, the Book Value Change Per Share is €-0.09 per quarter. Based on the YOY, the Book Value Change Per Share is €-1.12 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Pharnext.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps-2.20-1,098,051.4%-2.20-1,098,051.4%-3.07-1,534,140.1%-2.26-1,128,916.2%-1.77-886,618.4%
Usd Book Value Change Per Share-0.10-50,045.4%-0.10-50,045.4%-1.18-592,198.6%-0.12-60,702.1%-0.23-117,037.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.41206,182.9%0.21103,091.4%
Usd Total Gains Per Share-0.10-50,045.4%-0.10-50,045.4%-1.18-592,198.6%0.29145,480.8%-0.03-13,945.8%
Usd Price Per Share0.00-0.00-0.03-0.04-0.02-
Price to Earnings Ratio0.00-0.00--0.01--0.02--0.01-
Price-to-Total Gains Ratio0.00-0.00--0.02--0.09--0.06-
Price to Book Ratio0.00-0.00--0.01--0.03--0.01-
Price-to-Total Gains Ratio0.00-0.00--0.02--0.09--0.06-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.00021086
Number of shares4742483
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.41
Usd Book Value Change Per Share-0.10-0.12
Usd Total Gains Per Share-0.100.29
Gains per Quarter (4742483 shares)-474,678.841,379,880.43
Gains per Year (4742483 shares)-1,898,715.355,519,521.70
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-1898715-18987257822550-23030285519512
20-3797431-379744015645100-460605711039034
30-5696146-569615523467650-690908516558556
40-7594861-759487031290200-921211322078078
50-9493577-949358539112750-1151514127597600
60-11392292-1139230046935300-1381817033117122
70-13291007-1329101554757850-1612119838636644
80-15189723-1518973062580400-1842422644156166
90-17088438-1708844570402950-2072725449675688
100-18987154-1898716078225500-2303028355195210

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%0.011.00.00.0%
Book Value Change Per Share0.01.00.00.0%0.03.00.00.0%1.04.00.020.0%2.08.00.020.0%2.09.00.018.2%
Dividend per Share0.00.01.00.0%0.00.03.00.0%2.00.03.040.0%2.00.08.020.0%2.00.09.018.2%
Total Gains per Share0.01.00.00.0%0.03.00.00.0%2.03.00.040.0%3.07.00.030.0%3.08.00.027.3%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Pharnext SA compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.095-0.0950%-1.123+1083%-0.115+21%-0.222+134%
Book Value Per Share---2.570-2.5700%-2.475-4%-1.579-39%-1.328-48%
Current Ratio--0.4070.4070%0.302+35%1.000-59%1.376-70%
Debt To Asset Ratio--9.1399.1390%5.163+77%3.858+137%3.066+198%
Debt To Equity Ratio----0%-0%-0%0.498-100%
Dividend Per Share----0%-0%0.391-100%0.196-100%
Eps---2.083-2.0830%-2.910+40%-2.142+3%-1.682-19%
Gross Profit Margin--1.0001.0000%1.054-5%1.073-7%1.050-5%
Market Cap2642.1000%2642.1002642.1000%356683.500-99%549821.010-100%278609.445-99%
Net Profit Margin---2751.742-2751.7420%-68899.470+2404%-14529.190+428%-7266.718+164%
Operating Margin---2379.126-2379.1260%-53898.473+2165%-11445.020+381%-5724.468+141%
Operating Ratio--4324.6434324.6430%48653.357-91%10769.477-60%5386.973-20%
Pb Ratio0.0000%0.0000.0000%-0.011+13918%-0.029+37310%-0.014+18387%
Pe Ratio0.0000%0.0000.0000%-0.009+9563%-0.018+18139%-0.009+9216%
Price Per Share0.0000%0.0000.0000%0.027-99%0.042-100%0.021-99%
Price To Free Cash Flow Ratio----0%-0.0130%-0.0220%-0.0110%
Price To Total Gains Ratio-0.0020%-0.002-0.0020%-0.024+1041%-0.094+4369%-0.059+2700%
Quick Ratio--0.0070.0070%0.163-96%0.838-99%1.315-99%
Return On Assets---6.597-6.5970%-4.895-26%-3.075-53%-2.070-69%
Return On Equity----0%-0%-0%-0.4590%
Total Gains Per Share---0.095-0.0950%-1.123+1083%0.276-134%-0.026-72%
Usd Book Value---35795040.093-35795040.0930%-34472790.802-4%-21986451.062-39%-18492426.323-48%
Usd Book Value Change Per Share---0.100-0.1000%-1.184+1083%-0.121+21%-0.234+134%
Usd Book Value Per Share---2.710-2.7100%-2.609-4%-1.664-39%-1.400-48%
Usd Dividend Per Share----0%-0%0.412-100%0.206-100%
Usd Eps---2.196-2.1960%-3.068+40%-2.258+3%-1.773-19%
Usd Free Cash Flow----0%-28846435.5620%-19620601.4400%-16716207.9980%
Usd Market Cap2785.566+0%2785.5662785.5660%376051.414-99%579676.291-100%293737.938-99%
Usd Price Per Share0.0000%0.0000.0000%0.028-99%0.044-100%0.022-99%
Usd Profit---29011615.906-29011615.9060%-40533516.587+40%-29827032.612+3%-23425314.261-19%
Usd Revenue--10543.00010543.0000%588.299+1692%81802.294-87%2145254.216-100%
Usd Total Gains Per Share---0.100-0.1000%-1.184+1083%0.291-134%-0.028-72%
 EOD+1 -0MRQTTM+0 -0YOY+14 -125Y+10 -1810Y+8 -21

3.3 Fundamental Score

Let's check the fundamental score of Pharnext SA based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-150.000
Price to Book Ratio (EOD)Between0-10.000
Net Profit Margin (MRQ)Greater than0-2,751.742
Operating Margin (MRQ)Greater than0-2,379.126
Quick Ratio (MRQ)Greater than10.007
Current Ratio (MRQ)Greater than10.407
Debt to Asset Ratio (MRQ)Less than19.139
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-6.597
Total1/10 (10.0%)

3.4 Technical Score

Let's check the technical score of Pharnext SA based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5024.608
Ma 20Greater thanMa 500.000
Ma 50Greater thanMa 1000.000
Ma 100Greater thanMa 2000.001
OpenGreater thanClose0.000
Total0/5 (0.0%)

4. In-depth Analysis

4.1 About Pharnext SA

Pharnext S.C.A., a clinical-stage biopharmaceutical company, engages in developing novel therapies for neurodegenerative diseases. Its products in clinical development include PXT3003, a synergistic combination of baclofen, naltrexone, and sorbitol formulated as an oral solution for the treatment of charcot-marie-tooth disease type 1A; and PXT864, a novel fixed-dose synergistic combination of baclofen and acamprosate formulated as a pill for neurodegenerative diseases. The company was incorporated in 2007 and is headquartered in Suresnes, France.

Fundamental data was last updated by Penke on 2024-11-12 23:44:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Pharnext earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Pharnext to the Biotechnology industry mean.
  • A Net Profit Margin of -275,174.2% means that €-2,751.74 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Pharnext SA:

  • The MRQ is -275,174.2%. The company is making a huge loss. -2
  • The TTM is -275,174.2%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-275,174.2%TTM-275,174.2%0.0%
TTM-275,174.2%YOY-6,889,947.0%+6,614,772.8%
TTM-275,174.2%5Y-1,452,919.0%+1,177,744.8%
5Y-1,452,919.0%10Y-726,671.8%-726,247.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-275,174.2%-124.9%-275,049.3%
TTM-275,174.2%-208.9%-274,965.3%
YOY-6,889,947.0%-207.8%-6,889,739.2%
5Y-1,452,919.0%-351.9%-1,452,567.1%
10Y-726,671.8%-473.1%-726,198.7%
4.3.1.2. Return on Assets

Shows how efficient Pharnext is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Pharnext to the Biotechnology industry mean.
  • -659.7% Return on Assets means that Pharnext generated €-6.60 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Pharnext SA:

  • The MRQ is -659.7%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -659.7%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-659.7%TTM-659.7%0.0%
TTM-659.7%YOY-489.5%-170.2%
TTM-659.7%5Y-307.5%-352.2%
5Y-307.5%10Y-207.0%-100.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-659.7%-10.7%-649.0%
TTM-659.7%-11.7%-648.0%
YOY-489.5%-11.2%-478.3%
5Y-307.5%-12.6%-294.9%
10Y-207.0%-14.4%-192.6%
4.3.1.3. Return on Equity

Shows how efficient Pharnext is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Pharnext to the Biotechnology industry mean.
  • 0.0% Return on Equity means Pharnext generated €0.00 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Pharnext SA:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-45.9%+45.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--13.8%+13.8%
TTM--15.8%+15.8%
YOY--13.6%+13.6%
5Y--18.6%+18.6%
10Y-45.9%-19.1%-26.8%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Pharnext SA.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Pharnext is operating .

  • Measures how much profit Pharnext makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Pharnext to the Biotechnology industry mean.
  • An Operating Margin of -237,912.6% means the company generated €-2,379.13  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Pharnext SA:

  • The MRQ is -237,912.6%. The company is operating very inefficient. -2
  • The TTM is -237,912.6%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-237,912.6%TTM-237,912.6%0.0%
TTM-237,912.6%YOY-5,389,847.3%+5,151,934.7%
TTM-237,912.6%5Y-1,144,502.0%+906,589.5%
5Y-1,144,502.0%10Y-572,446.8%-572,055.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-237,912.6%-258.6%-237,654.0%
TTM-237,912.6%-304.6%-237,608.0%
YOY-5,389,847.3%-223.5%-5,389,623.8%
5Y-1,144,502.0%-389.5%-1,144,112.5%
10Y-572,446.8%-497.7%-571,949.1%
4.3.2.2. Operating Ratio

Measures how efficient Pharnext is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 4,324.64 means that the operating costs are €4,324.64 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Pharnext SA:

  • The MRQ is 4,324.643. The company is inefficient in keeping operating costs low. -1
  • The TTM is 4,324.643. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ4,324.643TTM4,324.6430.000
TTM4,324.643YOY48,653.357-44,328.713
TTM4,324.6435Y10,769.477-6,444.834
5Y10,769.47710Y5,386.973+5,382.505
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4,324.6432.760+4,321.883
TTM4,324.6433.393+4,321.250
YOY48,653.3573.299+48,650.058
5Y10,769.4774.814+10,764.663
10Y5,386.9736.536+5,380.437
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Pharnext SA.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Pharnext is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 0.41 means the company has €0.41 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Pharnext SA:

  • The MRQ is 0.407. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.407. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.407TTM0.4070.000
TTM0.407YOY0.302+0.104
TTM0.4075Y1.000-0.594
5Y1.00010Y1.376-0.376
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4073.709-3.302
TTM0.4073.886-3.479
YOY0.3024.684-4.382
5Y1.0005.946-4.946
10Y1.3766.274-4.898
4.4.3.2. Quick Ratio

Measures if Pharnext is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Pharnext to the Biotechnology industry mean.
  • A Quick Ratio of 0.01 means the company can pay off €0.01 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Pharnext SA:

  • The MRQ is 0.007. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.007. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.007TTM0.0070.000
TTM0.007YOY0.163-0.156
TTM0.0075Y0.838-0.831
5Y0.83810Y1.315-0.477
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0073.199-3.192
TTM0.0073.497-3.490
YOY0.1634.549-4.386
5Y0.8385.897-5.059
10Y1.3156.437-5.122
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Pharnext SA.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Pharnext assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Pharnext to Biotechnology industry mean.
  • A Debt to Asset Ratio of 9.14 means that Pharnext assets are financed with 913.9% credit (debt) and the remaining percentage (100% - 913.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Pharnext SA:

  • The MRQ is 9.139. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 9.139. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ9.139TTM9.1390.000
TTM9.139YOY5.163+3.976
TTM9.1395Y3.858+5.281
5Y3.85810Y3.066+0.791
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ9.1390.350+8.789
TTM9.1390.347+8.792
YOY5.1630.312+4.851
5Y3.8580.365+3.493
10Y3.0660.382+2.684
4.5.4.2. Debt to Equity Ratio

Measures if Pharnext is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Pharnext to the Biotechnology industry mean.
  • A Debt to Equity ratio of 0.0% means that company has €0.00 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Pharnext SA:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y0.498-0.498
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.393-0.393
TTM-0.437-0.437
YOY-0.374-0.374
5Y-0.450-0.450
10Y0.4980.493+0.005
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Pharnext generates.

  • Above 15 is considered overpriced but always compare Pharnext to the Biotechnology industry mean.
  • A PE ratio of 0.00 means the investor is paying €0.00 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Pharnext SA:

  • The EOD is 0.000. Based on the earnings, the company is expensive. -2
  • The MRQ is 0.000. Based on the earnings, the company is expensive. -2
  • The TTM is 0.000. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD0.000MRQ0.0000.000
MRQ0.000TTM0.0000.000
TTM0.000YOY-0.009+0.009
TTM0.0005Y-0.018+0.017
5Y-0.01810Y-0.009-0.009
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.000-2.225+2.225
MRQ0.000-2.362+2.362
TTM0.000-3.066+3.066
YOY-0.009-3.335+3.326
5Y-0.018-6.032+6.014
10Y-0.009-6.575+6.566
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Pharnext SA:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.013+0.013
TTM-5Y-0.022+0.022
5Y-0.02210Y-0.011-0.011
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--3.177+3.177
TTM--3.575+3.575
YOY-0.013-4.527+4.514
5Y-0.022-8.367+8.345
10Y-0.011-9.230+9.219
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Pharnext is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 0.00 means the investor is paying €0.00 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Pharnext SA:

  • The EOD is 0.000. Based on the equity, the company is expensive. -2
  • The MRQ is 0.000. Based on the equity, the company is expensive. -2
  • The TTM is 0.000. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD0.000MRQ0.0000.000
MRQ0.000TTM0.0000.000
TTM0.000YOY-0.011+0.011
TTM0.0005Y-0.029+0.029
5Y-0.02910Y-0.014-0.015
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.0001.893-1.893
MRQ0.0002.003-2.003
TTM0.0002.302-2.302
YOY-0.0112.390-2.401
5Y-0.0293.666-3.695
10Y-0.0144.354-4.368
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2019-12-312020-12-312021-12-312022-12-312023-12-31
Other Current Assets  7573,3974,154-1,9102,2446952,940-2,9400
Reconciled Depreciation  525230754-92662-83579-688-109
Depreciation and Amortization  5258421,367-1601,206-536670-779-109



6.2. Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in EUR. All numbers in thousands.

Summary
Total Assets4,172
Total Liabilities38,123
Total Stockholder Equity-33,951
 As reported
Total Liabilities 38,123
Total Stockholder Equity+ -33,951
Total Assets = 4,172

Assets

Total Assets4,172
Total Current Assets3,865
Long-term Assets307
Total Current Assets
Cash And Cash Equivalents 13
Net Receivables 54
Total Current Assets  (as reported)3,865
Total Current Assets  (calculated)67
+/- 3,798
Long-term Assets
Property Plant Equipment 39
Long-term Assets Other 267
Long-term Assets  (as reported)307
Long-term Assets  (calculated)307
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities9,502
Long-term Liabilities28,621
Total Stockholder Equity-33,951
Total Current Liabilities
Short-term Debt 1
Short Long Term Debt 1
Accounts payable 7,627
Other Current Liabilities 272
Total Current Liabilities  (as reported)9,502
Total Current Liabilities  (calculated)7,900
+/- 1,601
Long-term Liabilities
Long term Debt 26,168
Long-term Liabilities Other 1,900
Long-term Liabilities  (as reported)28,621
Long-term Liabilities  (calculated)28,068
+/- 554
Total Stockholder Equity
Common Stock179
Retained Earnings -40,012
Accumulated Other Comprehensive Income 1,969
Other Stockholders Equity 3,913
Total Stockholder Equity (as reported)-33,951
Total Stockholder Equity (calculated)-33,951
+/-0
Other
Capital Stock179
Cash and Short Term Investments 13
Common Stock Shares Outstanding 140
Current Deferred Revenue1,602
Liabilities and Stockholders Equity 4,172
Net Debt 26,155
Net Invested Capital -7,783
Net Working Capital -5,637
Property Plant and Equipment Gross 461
Short Long Term Debt Total 26,168



6.3. Balance Sheets Structured

Currency in EUR. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
> Total Assets 
16,233
8,526
10,145
6,235
22,738
19,306
30,998
23,172
21,254
16,452
7,855
4,172
4,1727,85516,45221,25423,17230,99819,30622,7386,23510,1458,52616,233
   > Total Current Assets 
15,700
8,156
9,850
6,092
22,241
18,558
29,664
21,645
20,398
15,545
6,400
3,865
3,8656,40015,54520,39821,64529,66418,55822,2416,0929,8508,15615,700
       Cash And Cash Equivalents 
12,129
5,151
7,237
3,089
16,670
12,455
22,761
14,247
11,078
7,968
595
13
135957,96811,07814,24722,76112,45516,6703,0897,2375,15112,129
       Short-term Investments 
0
65
0
0
0
2,001
2,004
2,000
-201
0
0
0
000-2012,0002,0042,001000650
       Net Receivables 
0
2,831
2,547
2,988
4,841
5,311
6,108
4,642
5,166
5,333
2,865
54
542,8655,3335,1664,6426,1085,3114,8412,9882,5472,8310
       Inventory 
0
0
0
15
-4,841
-5,311
-6,108
0
0
2,244
2,940
0
02,9402,24400-6,108-5,311-4,84115000
   > Long-term Assets 
534
370
295
92
104
192
433
1,527
855
906
1,454
307
3071,4549068551,52743319210492295370534
       Property Plant Equipment 
133
26
50
34
66
136
401
879
161
322
1,052
39
391,05232216187940113666345026133
       Long Term Investments 
0
4
4
0
0
0
0
0
0
0
0
0
000000000440
       Intangible Assets 
13
1
35
58
38
56
32
12
7
0
0
0
0007123256385835113
       Long-term Assets Other 
388
405
210
-92
-104
-192
-433
434
486
383
403
267
267403383486434-433-192-104-92210405388
> Total Liabilities 
11,754
13,148
23,042
29,934
18,937
31,296
57,343
30,418
33,773
34,308
40,552
38,123
38,12340,55234,30833,77330,41857,34331,29618,93729,93423,04213,14811,754
   > Total Current Liabilities 
4,115
6,011
15,575
19,345
9,730
7,875
9,362
9,960
15,517
19,305
21,167
9,502
9,50221,16719,30515,5179,9609,3627,8759,73019,34515,5756,0114,115
       Short-term Debt 
454
2,391
10,437
13,481
3,581
1,659
1,037
4,167
4,214
9,005
3,978
1
13,9789,0054,2144,1671,0371,6593,58113,48110,4372,391454
       Short Long Term Debt 
0
9,046
10,438
13,481
3,581
1,659
0
3,806
3,926
8,713
3,314
1
13,3148,7133,9263,80601,6593,58113,48110,4389,0460
       Accounts payable 
1,759
1,618
891
1,208
4,862
3,854
6,901
3,710
8,430
5,528
6,087
7,627
7,6276,0875,5288,4303,7106,9013,8544,8621,2088911,6181,759
       Other Current Liabilities 
1,313
1,377
1,426
18,137
792
1,059
2,461
973
2,018
4,174
10,759
272
27210,7594,1742,0189732,4611,05979218,1371,4261,3771,313
   > Long-term Liabilities 
7,639
7,137
7,467
10,121
8,741
22,872
47,435
20,458
18,256
15,003
19,385
28,621
28,62119,38515,00318,25620,45847,43522,8728,74110,1217,4677,1377,639
       Other Liabilities 
0
484
702
467
466
548
547
603
1,235
1,803
0
0
001,8031,2356035475484664677024840
> Total Stockholder Equity
4,479
-4,622
-12,897
-23,698
3,800
-11,989
-26,345
-7,246
-12,519
-17,857
-32,697
-33,951
-33,951-32,697-17,857-12,519-7,246-26,345-11,9893,800-23,698-12,897-4,6224,479
   Common Stock
63
63
64
64
108
112
121
153
194
1,315
368
179
1793681,31519415312111210864646363
   Retained Earnings -40,012-57,224-159,588-128,920-107,438-83,862-62,290-41,748-58,171-47,356-36,686-27,521
   Accumulated Other Comprehensive Income 
-418
-546
-583
-25
56
65
709
740
2,356
3,771
4,308
1,969
1,9694,3083,7712,3567407096556-25-583-546-418
   Capital Surplus 000000000000
   Treasury Stock000000000000
   Other Stockholders Equity 
32,356
32,548
34,978
34,408
45,384
50,123
56,686
99,300
113,852
136,645
19,851
3,913
3,91319,851136,645113,85299,30056,68650,12345,38434,40834,97832,54832,356



6.4. Balance Sheets

Currency in EUR. All numbers in thousands.




6.5. Cash Flows

Currency in EUR. All numbers in thousands.




6.6. Income Statements

Currency in EUR. All numbers in thousands.


6.7. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in EUR. All numbers in thousands.

Gross Profit (+$)
totalRevenue10
Cost of Revenue-19,349
Gross Profit-19,339-19,339
 
Operating Income (+$)
Gross Profit-19,339
Operating Expense-23,898
Operating Income-23,888-43,236
 
Operating Expense (+$)
Research Development18,191
Selling General Administrative0
Selling And Marketing Expenses0
Operating Expense23,89818,191
 
Net Interest Income (+$)
Interest Income0
Interest Expense-2,599
Other Finance Cost-0
Net Interest Income-2,599
 
Pretax Income (+$)
Operating Income-23,888
Net Interest Income-2,599
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-28,303-19,472
EBIT - interestExpense = -26,390
-28,303
-24,919
Interest Expense2,599
Earnings Before Interest and Taxes (EBIT)-23,791-25,704
Earnings Before Interest and Taxes (EBITDA)-23,900
 
After tax Income (+$)
Income Before Tax-28,303
Tax Provision--785
Net Income From Continuing Ops-27,517-27,517
Net Income-27,517
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses23,898
Total Other Income/Expenses Net-4,4152,599
 

Technical Analysis of Pharnext
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Pharnext. The general trend of Pharnext is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Pharnext's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Pharnext SA.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.0002 < 0.0002 < 0.0002.

The bearish price targets are: 0.0001 > 0.0001 > 0.0001.

Tweet this
Pharnext SA Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Pharnext SA. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Pharnext SA Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Pharnext SA. The current macd is -0.000021.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Pharnext price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Pharnext. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Pharnext price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Pharnext SA Daily Moving Average Convergence/Divergence (MACD) ChartPharnext SA Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Pharnext SA. The current adx is 24.92.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Pharnext shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Pharnext SA Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Pharnext SA. The current sar is 0.0002.

Pharnext SA Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Pharnext SA. The current rsi is 24.61. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 1/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
Pharnext SA Daily Relative Strength Index (RSI) ChartPharnext SA Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Pharnext SA. The current phase is Overbought in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Pharnext price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Pharnext SA Daily Stochastic Oscillator ChartPharnext SA Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Pharnext SA. The current cci is 66.67.

Pharnext SA Daily Commodity Channel Index (CCI) ChartPharnext SA Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Pharnext SA. The current cmo is -32.06475993.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Pharnext SA Daily Chande Momentum Oscillator (CMO) ChartPharnext SA Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Pharnext SA. The current willr is 0.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Pharnext SA Daily Williams %R ChartPharnext SA Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Pharnext SA.

Pharnext SA Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Pharnext SA. The current atr is 0.00011211.

Pharnext SA Daily Average True Range (ATR) ChartPharnext SA Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Pharnext SA. The current obv is -189,203,640.

Pharnext SA Daily On-Balance Volume (OBV) ChartPharnext SA Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Pharnext SA. The current mfi is 0.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Pharnext SA Daily Money Flow Index (MFI) ChartPharnext SA Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Pharnext SA.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-05CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-07-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-10STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-07-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-19MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-07-22STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-07-24STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-07-29MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-08-01MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-08-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-06SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-08MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-08-09MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-08-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-08-13STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-19STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-23WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-02WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-09-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-12MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-09-13MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-10-03SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.

6.3. Candlestick Patterns

Pharnext SA Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Pharnext SA based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5024.608
Ma 20Greater thanMa 500.000
Ma 50Greater thanMa 1000.000
Ma 100Greater thanMa 2000.001
OpenGreater thanClose0.000
Total0/5 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Pharnext with someone you think should read this too:
  • Are you bullish or bearish on Pharnext? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Pharnext? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Pharnext SA

I send you an email if I find something interesting about Pharnext SA.


Comments

How you think about this?

Leave a comment

Stay informed about Pharnext SA.

Receive notifications about Pharnext SA in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.